Research study Program year 2025 Source: CMS Open Payments

A Two-Part, Randomized, Placebo Controlled, Double Blind, Multicenter,

Research payments

$8,688,994

816 payments

Through program year 2025, $8,688,994 in research payments was reported against A Two-Part, Randomized, Placebo Controlled, Double Blind, Multicenter,, across 816 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$574,963	149
2024	Research	$1,547,088	303
2023	Research	$1,299,531	213
2022	Research	$2,877,401	141
2021	Research	$2,390,011	10

Breakdown

Who paid Research payments · program years 2021–2025

GlaxoSmithKline, LLC. $8,688,994 816 payments

Who received the money Research payments · program years 2021–2025

Science37 INC Organisation paid for research $7,341,363 84 payments
Duke University Organisation paid for research $123,625 108 payments
University Of Miami Organisation paid for research $121,338 113 payments
Cedars Sinai Medical Center Organisation paid for research $118,035 42 payments
The Ohio State University Organisation paid for research $108,290 41 payments
University Of California Organisation paid for research $105,869 39 payments
Henry Ford Health System Organisation paid for research $77,241 39 payments
Pharmaseek LLC Organisation paid for research $58,032 24 payments
Regents University Of California Los Angeles Organisation paid for research $57,684 41 payments
NYU School of Medicine Organisation paid for research $56,576 31 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.